PDCD1 and breast cancer: We evaluated the antitumour activity of 015s in comparison to anti-PD-1 (αPD-1), soluble TGF-βRII, and the αPD-1 + TGF-βRII combination in BALB/c mice bearing orthotopic EMT-6 mammary tumours (Figure 3A).